The c-Myb oncoprotein is known to bind to multiple sites in the promoters of target genes. We have developed a protocol to screen the binding site of c-Myb by using the systematic binding data derived from measurements of binding affinity for oligonucleotide containing a known Myb-binding site and its complete single mutants. We first applied the method to predict the binding affinity for the known binding sites and compared with available experimental data. The predicted binding sites agree with many putative binding sites of known target promoters. However, there are some binding sites not predicted by the analysis. These sequences deviate from the consensus sequence derived from the binding analyses. In the light of the structure of Myb-DNA complex, these results indicate that different DNA-binding modes may be used by c-Myb to recognize different classes of binding sites. We also screened the sequence database for potential Myb-binding sites, and found sequences of several promoters that have not been identified experimentally but could be the target for c-Myb.
INTRODUCTION
C-myb is a proto-oncogene encoding a nuclear protein (c-Myb) that binds to DNA (1, 2) . Its analog, v-myb, also encodes a nuclear protein, which is characterized by N-and C-terminal truncations compared with c-Myb. The c-Myb protein is supposed to function as an activator as well as a repressor of transcription (reviewed in 3,4), regulating genes important for cell growth and development. Myb expression was initially thought to be largely restricted to the hematopoietic system, but recently, it was also demonstrated to be involved in the regulation of proliferation and differentiation of various types of cells other than hematopoietic cells (5, 6) .
The c-Myb protein is comprised of three domains responsible for DNA binding, transcriptional activation and negative regulation (7) . The DNA-binding domain of Myb protein is located at the N-terminal side and consists of three homologous tandem repeats of 51 or 52 amino acids (designated as R1, R2 and R3 from the N terminus). Each repeat has three conserved tryptophans spaced 18 or 19 residues apart. This repeat structure with conserved tryptophans seems to be a general motif utilized in many different transcription activators found in a wide spectrum of eukaryotes, including vertebrates, insects, yeast, cellular slime mold and higher plants (4, 8, 9) . Among the three repeats of the DNA-binding domain, R1 can be deleted without significant loss of DNA-binding activity (7, 10) and plays a minor role in sequence recognition. Domains R2 and R3 are necessary and sufficient for the recognition of specific DNA sequences (2, 7, 10) . Thus, the minimum DNA-binding domain is the R2R3 fragment.
The NMR analysis of the Myb DNA-binding domain revealed that the three repeats in the DNA-binding domain have similar overall structures, each containing three helices (11) (12) (13) . The second and the third helices form a helix-turn-helix (HTH) variation motif, which contains a longer turn than the one in the prototypical HTH motif. The NMR analysis of the Myb-DNA complex showed that R2 and R3 are closely packed in the major groove with each of the third helices acting as the recognition helix (12) . In contrast, R1 was shown to have no specific interactions with DNA (12, 14) .
The c-Myb protein can activate or repress the transcription of several potential target genes. So far, the known target genes include promyelocyte-specific mim-1 gene (15) , cdc2 gene (16) , gene encoding PR264 splicing factor (17) , c-myc proto-oncogene (18, 19) and c-myb itself (20) , as well as the long-terminal repeat (LTR) promoters of the human immunodeficiency virus type-1 (HIV-1) (21) and the human T-lymphotrophic virus type-I (HTLV-I) (22) . Other genes trans-activated by c-Myb include CD4 (23) , CD34 (24) and T cell receptor δ (25) . In addition, c-Myb also binds to c-erbB-2 (26) , which is the only known gene repressed by c-Myb so far.
The Myb-recognition element (MRE) was originally defined as YAACKG, where K stands for G or T, as derived from comparisons of isolated chicken DNA-binding sites for v-Myb (27) . Then, two extended consensus sequences, the 9-bp YGRCGTTR motif (28) , where Y and R denote pyrimidines and purines, respectively, and the 8-bp YAACKGHH motif (29) , where H denotes A, C or T (i.e. not G), were obtained from binding-site selection protocols.
In order to characterize qualitatively the sequence specificity in c-Myb binding, we have carried out an extensive binding analysis by using the Myb-binding site, MBS-I, in SV40 (30) . By using a synthesized oligonucleotide containing this binding site, the binding affinities to the c-Myb DNA-binding domain were measured by filter-binding assay and the effects of systematic base-pair substitutions on binding affinity were examined (14) . Such analyses have provided valuable information about the location and energetic contributions of specific interactions (31, 32) . The mutational analyses have shown that the specific interactions are not uniformly distributed in the TAACTGAC region of MBS-I; the 2nd A, the 4th C and the 6th G are involved in very specific interactions with Myb, whereas the interactions at the 3rd A and the 8th C are less specific (14) . A set of binding affinity changes or binding free energy changes, ∆∆G, due to base substitutions defines a consensus recognition sequence in a quantitative sense.
Although c-Myb is thought to regulate transcription in multiple genes, there is no efficient method to identify its target genes. In this paper, we apply the above binding analysis to approach this problem, by using the experimental ∆∆G data to predict putative binding sites. In order to test the predictive capacity of this method, we first examined the binding sites in the known target genes and compared these with available experimental data. We have also applied the protocol to seek potential Myb-binding sites in the sequence database, and found a number of binding sites in the promoters of genes that have not yet been verified as targets of Myb by experiments but may be potentially important for the function of c-Myb. Finally, we discuss the multiple-binding mechanism of Myb by comparing the present results with available structural and functional information about Myb.
METHOD OF CALCULATIONS
Previously we carried out an extensive binding analysis on c-Myb (14) . We introduced complete single mutations at each position of the 22mer oligonucleotide containing the MBS-I site in SV40, and measured binding affinities by filter-binding assays. The binding affinity ratio, K(wild)/K(mutant), or the binding free energy change, ∆∆G = RTlnK(wild)/K(mutant), between the original MBS-I and its mutants can provide information about the location and magnitude of specific interactions within the binding region, as has been shown for Cro and λ repressor (31, 32) .
The ∆∆G values for each base position with respect to three substituted bases define a matrix, as shown in Table 1 , which can be used to calculate the binding strength of any sequence as long as the ∆∆G values are independent (see Discussion). The binding strength for a given segment of sequence can be calculated simply by summing individual contribution of ∆∆G at each base position (the total free energy change will be denoted as ∆∆G tot ). Note that positive values of ∆∆G mean that a mutation weakens the binding, and every 10-fold change in the binding affinity corresponds to a 1.3 kcal/mol change in ∆∆G. The ∆∆G tot for each segment in a certain region of DNA can be calculated by moving the window, base by base, along the sequence. In the calculations, both directions were considered, in order to include both strands. In screening for potential Myb binding sites, all the human genes in the sequence database (primate subsection) were searched for potential Myb target sites in promoters and enhancers. 
RESULTS

Screening of binding sites for known target genes
Myb protein has been shown to bind within the promoter regions of several potential target genes, including promyelocyte-specific mim-1 gene (15), cdc2 gene (16), gene encoding PR264 splicing factor (17), c-myc proto-oncogene (18, 19) , c-myb itself (20) , LTR sequences of HIV-1 (21) and HTLV-I (22), c-erbB-2 (26) , and in the enhancer domain of SV40 (30) . These known target genes were screened by the present protocol to look for putative binding sites and then compared with experimental data. All the numberings of the sequences follow the original GenBank entry, and the notations of the putative binding sites follow the corresponding references.
SV40
. Nakagoshi et al. (30) found that binding of c-Myb to the simian virus enhancer stimulates transcription. There is a c-Myb-binding site, MBS-I, in the enhancer domain of SV40. We calculated ∆∆G tot along the whole SV40 sequence. Plotted in Figure 1A is <∆∆G tot > -∆∆G tot , so that the larger its value, the stronger the affinity. The highest point is at position 256, corresponding to the binding site MBS-I in SV40 (30) . In Figure  1B , we draw possible binding sites whose ∆∆G tot are lower than the threshold value, ∆∆G threshold . Here, the binding sites on the opposite strand are also included. This figure shows the putative binding sites more clearly. Figure 1C Table 1 ). In the MBS-I sequence, positions 2, 4 and 6 are A, C and G, respectively. Any mutations at these positions cause ∆∆G to be as high as ∼4 kcal/mol. Position eight is C and ∆∆G is 4.2 kcal/mol if it is mutated to a G. Except at these positions, all the other positions are not as sensitive to the mutations, with quite small ∆∆G. These insensitive mutations produce a baseline with energy ranging from 1 to 2 kcal/mol. Random sequences can have one, two or three mutations among positions 2, 4 and 6. Thus, this will produce peaks at energies around 6, 10 and 14 kcal/mol. If at the same time position eight is G, these peaks will be shifted to 10, 14 and 18 kcal/mol, respectively. Hence, there are four peaks in the histogram. The peaks at 10 and 14 kcal/mol are higher than the other two, because these peaks always exist regardless of the mutation at position eight.
affinities. Sites A and B showed stronger Myb-binding activity than did site C. Figure 2A shows the results from the binding-site search. The three sites A, B and C were found among the screened sites, agreeing with the DNase I footprinting (15) . Interestingly, sites A and B are accompanied by minor sites at their 3′ side. This is consistent with the higher binding affinities of these sites. The three binding sites are located within an 80-bp region, and separated by 40 and 20 bp, suggesting that they may face the same side of the double helix. Such features may be exploited to interact with other factors in a cooperative manner. Figure 2B shows the binding histogram for all the segments in the mim-1 gene. The three arrows indicate the locations of the three putative binding sites. All three sites are located within the lowest 1% of the ∆∆G tot .
C-myc. C-myc is one of the genes known to be trans-activated by c-Myb (18, 19) . Transcription of c-myc starts from at least three initiation sites with distinct promoters P0, P1 and P2. Zobel et al. (18) analyzed the binding activities of the purified proteins with five DNA restriction fragments of the regulatory region by gel-shift assays. The five segments used were F1(2945-3128), F2(2037-2173), F3(1074-1269), F4(875-982) and F5(484-632). The results showed that the affinities for the five segments are different: binding to F3 was the strongest; binding affinities to F1, F4 and F5 were similar, and ∼10-fold lower than to F3; and binding to F2 was the lowest. The DNase I footprinting assay identified eight binding sites, denoted as F1-H, F1-L; F3-H, F3-L; F4-H, F4-L and F5-H, F5-L, respectively.
From the binding-site screening of c-myc gene, seven out of the eight binding sites were found (Fig. 3A) . The only missing one is F4-L. In F2, three sites were found but with very low affinity, agreeing with the gel-shift result showing F2 very low binding affinity. F3 has five sites, among which the two strongest sites indeed correspond to F3-H and F3-L. F3-H has a 2-fold symmetric sequence with two AACs, and F3-L accompanies a minor site at the 5′ side. Thus, these results agree nicely with the experimental observation that F3 is the strongest Myb-binding fragment (18) 3A) is sufficient for the Myb-induced trans-activation. They found 10 binding sites (designated as 1-10), which were almost completely protected by 100 ng of c-Myb in the DNase I footprinting analysis. Five out of the 10 sites were found to be strong to medium binding sites by the present binding-site screening (Fig. 3A) . From the present binding-site screening, three out of the four binding sites were found (Fig. 4A) . The three strongest sites fall within fragment 2, and the two strongest binding sites correspond to H1 and L1 mentioned above, consistent with the observed strong binding activity of this fragment. Both fragments 3 and 4 contain several medium-affinity sites, among which the strongest one corresponds to L1 and belongs to both fragments. However, the present analysis failed to pick up the high-affinity binding site H2 in fragment 4. This is because the eighth base in the CAACGGAG sequence of the H2 site is G, which is unfavorable according to the binding analysis (14; see also Table 1) . Dasgupta et al. (21) also showed that there is one Myb-binding motif YAACKG in the HIV LTR sequence. They carried out a similar analysis by generating overlapping DNA fragments, in which several putative Myb-binding sites were identified. The present binding-site screening qualitatively agrees with these experimental results (not shown).
PR264. Human PR264 promoter sequences contain several MREs (17) . DNase I footprinting analysis revealed 11 Mybbinding sites (denoted A-K). Figure 5A shows the result from the binding-site screening. Out of the 11 binding sites, nine were found by the screening. Table 2 shows a comparison of the calculated results for each experiment (17) . The calculated results fit well with those from gel-shift and footprint experiments. Site A was indicated by the experiments to be the weakest binding site among all the sites (17) . In the screening, ∆∆G tot for this site exceeds 3 kcal/mol (Fig. 5B) , and thus was not selected by the prediction. Sites B, C and E are the three strongest sites in Figure 5A and form the leftmost cluster in the binding histogram (Fig. 5B ), in agreement with the observed strong activity (17) ; whereas sites D, F, J and K are lower than those three sites and form the second cluster in the histogram. This agrees with the observed weaker binding affinity (17) . On the other hand, sites G, H and I, which were indicated as strong binding sites by DNase I footprinting assays, were predicted to be weak binding sites. In the case of site H, the fourth position of AAAGCGTT is G instead of the consensus C.
Cdc2. Ku et al. (16) showed that there are two MREs in a 465 bp 5-flanking sequence of cdc2 gene, which exhibited promoter activity as revealed by transient CAT expression analysis. Two putative MREs are located very near to 660. However, these binding sites were not detected by the present binding-site search. The sequences of the two binding sites are TAACTATA and TAACCCTA, where the sixth positions are not G, deviating from the general motif yAaCkG. Thus, ∆∆G tot for these two sites is ∼5 kcal/mol. These two sites are spaced very closely, with only 14 bp between the centers of the binding sites. They are also located on the same strand. This may indicate that when Myb binds to adjacent binding sites cooperatively, the recognition at the 6th position may become redundant (see Discussion). There are some binding sites with medium strength in the other region (such as positions at 803 and 833) of the cdc2 promoter, which may also contribute to trans-activation (see the next section). (20) found multiple MREs in the region from 71 to 112, and site I (centered at 110) and site II (centered at 96) are likely to be functionally important. However, neither site I nor site II was found in the present search. Like the cdc2 gene, the two sites contain the sequence TAACNT, which deviates from the consensus at the sixth G position, and have similar ∆∆G tot s ∼5 kcal/mol. Also, these two sites are located very close to each other, with 14 bp between the centers of the binding sites. Thus, the same reasoning as above may explain the discrepancy. Although these two sites were not found in the screening, other sites such as the one centered at 149 were found, which may contribute to c-myb autoregulation.
C-myb. The c-myb gene itself is autoregulated by Myb protein (20). Nicolaides et al.
C-erbB-2.
While c-Myb activates the genes mentioned so far, it can also repress the promoter containing MREs. C-erbB-2 is a natural target gene which is the only one known so far to be repressed by c-Myb. Mizuguchi et al. (26) showed that the DNA binding domain of c-Myb was required and was sufficient for trans-repression of the c-erbB-2 promoter activity. DNase I footprinting analyses revealed that six sites (I-VI) were almost completely protected. Among them, sites I and III are suggested to be responsible for c-Myb-induced trans-repression. From the present binding-site search, only the sites II and IV were found. The other four sites could not be detected because of their deviation from the consensus sequence at the sixth G position; these binding sites have A, T or C at this position.
Screening of potential Myb target genes from the sequence database
C-Myb has been thought to be involved in regulation of transcription in multiple genes. So far, only a limited number of target genes have been demonstrated (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) . Identification of the target genes is important for understanding the role of transcription factors in many biological events such as development. However, we have had no efficient method to identify them. Usually, a differential screening using the cells expressing or lacking the specific transcription factor is used to identify target genes. However, finding target genes is difficult, as expression can be rapidly induced or modulated only at low level. Furthermore, this method is fairly laborious. Therefore, if some candidates for target genes can be identified by rapid screening procedure it would be very useful. Thus, we have developed and applied the present protocol to screen the sequence database for unknown but potentially important Myb-binding sites. We have searched the database (primate subsection) for human genes with putative Myb binding sites in regulatory regions which have not yet been identified experimentally. We first examined different criteria for the screening, as shown in Table  3 . Because Myb-binding sites are usually present in multiples, we also incorporated such a condition into the screening. The multi-site condition greatly reduces the number of hits, as shown in Table 3 . We started with a large pool of these binding sites listed in Table 3 , and narrowed down to only those binding sites in the regulatory regions. Then, we further selected only those binding sites that have not been verified by experimentation but may be interesting for the functional aspects of c-Myb, as shown in Table  4 (the screening program and a library of potential Myb-binding sites listing all entries and binding sites in Table 3 are available upon request). a L represents the size of the region within which the specified number of binding sites are found. b The search was carried out for all sequences in the primate section of GenBank (Rel.91). Thus, the numbers shown here represent all hits including the sites within coding regions.
These candidate genes can be classified into seven groups based on the function of their gene products, as shown in Table 4 . Mammalian c-Myb is required for the G1/S transition in the cell cycle, and Drosophila Myb has recently been speculated to be necessary for G2/M transition (33) . In this sense, four candidates encoding cyclins and cdc25 phosphatase, together with cdc2 mentioned before, are interesting. Recently, a specific region containing two elements called CDE (cell cycle-dependent element) and CHR (cell cycle homology region) in the cyclin A, cdc25C and cdc2 genes was demonstrated to be responsible for the cell cycle-dependent transcription of these genes (34) . Interestingly, our search identified multiple Myb-binding sites adjacent to this region in these genes. Therefore, it is important to examine whether Myb is involved in the cell cycle-dependent transcriptional regulation of these genes through binding to them. The level of c-Myb expression is high in immature hematopoietic cells, and downregulated during differentiation, indicating that c-Myb is important for maintaining the proliferative state of hematopoietic progenitor cells (35) . Those genes classified as proto-oncogenes and their related genes are important for supporting cellular proliferation. Especially, the c-kit gene is a good candidate for the Myb target gene, because it encodes the receptor for stem cell factor that is necessary for growth of immature hematopoietic cells. Among those genes encoding transcription factors, the ets-1, c-src, and NF-κB genes encode the transcription factors that positively regulate cellular proliferation, implying that their expression could be activated by c-Myb. In contrast, IκB-α and Id2A are inhibitor of NF-κB and the helix-loop-helix-type factor, respectively. In addition, CP2 is an activator of the α-globin gene, a typical terminal differentiation marker. Therefore, these genes could be repressed by c-Myb. The genes encoding the negative regulators of cell growth such as tumor suppressor genes are also candidates for c-Myb targets, whose expression is repressed by c-Myb. In addition to the role in maintaining the proliferative state of immature hematopoietic cells, c-Myb is also important for growth control of differentiated cells. For example, the level of c-myb mRNA is transiently increased after stimulation of resting mature T cells by IL-2 (36). In addition, a similar increase in the c-myb mRNA level is also found in serum stimulated smooth muscle cells (5) . In this aspect, the genes encoding cytokines, their receptors, receptors involved in immune response, and regulators of signal transduction are all candidates for Myb target genes.
DISCUSSION
We have examined the binding site of c-Myb by using the binding free energy data derived from extensive binding analyses. The ∆∆G values used here define a consensus sequence recognized by c-Myb in a quantitative manner so that they can be used to predict other potential binding sites for c-Myb. However, such a prediction is valid only if the ∆∆G values are additive with respect upon base substitution. Although the condition holds in most cases for Cro and λ repressor (31, 32) , it has not been proven for c-Myb. The non-uniform ∆∆G values over the binding region usually indicate the presence of local contacts between amino acids and base pairs with different interaction strengths. A recent paper (37) compared such apparent strengths across several different molecular systems and experimental approaches, including sequence variability, and found strong correlations for the strongly interacting base-amino acid pairs. Thus, the individual base-amino acid strengths might be quite general across different molecular systems.
In order to test the predictive capacity of the method in the case of c-Myb, we first examined the binding sites for the known target genes and compared them with the available experimental data. The results showed that our protocol can identify many putative binding sites and potential target genes. On the other hand, there are several cases where binding sites were not predicted by the analysis. Interestingly, a close inspection of these binding sites shows that the second A and fourth C in the consensus sequence, yAaCkGNH, derived from the systematic binding analyses (14) are almost perfectly conserved, except for F4-L of c-myc, where the fourth C is instead a T. On the other hand, the sixth G is not conserved in several sites of c-myc, c-myb, PR264, cdc2, c-erbB-2; there seems to be no specific base preference at this position for these sites. Also, the eighth position is occupied by G in a few cases. Table 1 ). *Binding sites where the ∆∆G tot value is <1.0 kcal/mol (thus, stronger binding expected). For the multiple binding sites in which there are more than two sites within a 50-bp region, numbers are separated by '/', whereas they are separated by a comma otherwise. We listed only one single-binding site and one multiple-binding site with the lowest ∆∆G tot if there is more than one such site.
The structure of the Myb-DNA complex solved by NMR analysis (12) shows that Asn-183 and Lys-182 from R3 interact with the second A and fourth C, respectively; whereas the sixth G interacts with Lys-128 from R2. Thus, the interaction of R3 appears to be conserved throughout these binding sites. On the other hand, the interaction of R2 for these binding sites appears to be different from the other sites; R2 seems not to specify bases at the sixth position, so that this interaction may be absent in binding to these sites.
We cannot preclude the possibility that some of the above binding sites are not real targets for c-Myb, but the significant deviation from the consensus sequence for a number of sites indicates that the ∆∆G values may not be strictly additive. The breakdown of the additivity may be mainly attributed to (i) cooperative interactions within single binding site, or (ii) cooperative interactions among different binding sites. As an example of the former case, even small conformational changes in the DNA by a base substitution could affect substitutions at other positions in the same site. On the other hand, multiple Myb-binding sites are often present in promoters, and Myb molecules may interact with themselves or other molecules in the transcriptional machinery. Therefore, we can naturally expect a certain level of cooperativity in the binding of c-Myb to DNA. In fact, it has been reported that a oligonucleotide sequence containing duplicated Myb-binding motif showed a higher affinity than the sequence with only a single Myb-binding motif (10) .
The good correlation between the observed interactions in the myb-DNA complex structure and those base positions indicated by the binding analysis to have specific interactions indicates that no major problem arising in the additivity of the individual ∆∆Gs because of the cooperativity within single binding site is anticipated. Rather, we suggest that c-Myb may use different modes of binding in recognizing the multiple binding sites of the target promoters. As shown earlier, there are multiple potential binding sites, some of which are closely located or spaced with a period of 10 bp. The proximity and/or phasing of binding sites may cause cooperative interactions of multiple Myb molecules via direct contact, DNA bending, or through other transcription factors. When c-Myb binds to multiple binding sites cooperatively, the binding mode of R2 could be different from that in the case of single-site binding.
The present protocol was also applied to the screening of potential binding sites of c-Myb that have not been verified by experiments, and we have been able to identify some additional interesting binding sites by the screening, that can be targets of c-Myb. It should be emphasized that certain classes of sequences mentioned above escape the present screening. Thus, the screened results represent a subset library of potential Mybbinding sites, and they are by no means a complete library. The screening protocol is straightforward given the ∆∆G values, and parameters such as the ∆∆G threshold and the number of binding sites within a specified range can be varied to control the screening. The binding-site library will of course grow with the rapidly increasing sequence database. The present method may provide useful information on the function of c-Myb as a transcriptional regulator for multiple genes.
